Scientists probe why tezepelumab doesn't stop all asthma attacks
NCT ID NCT06666504
First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time
Summary
This observational study looks at why some people with severe asthma continue to have flare-ups even while taking tezepelumab, an approved treatment. Researchers will track 150 patients over a year, measuring changes in inflammatory cells and markers in blood and airways during an attack compared to stable periods. The goal is to better understand the underlying causes of these breakthrough exacerbations.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
tezepelumab
What this could lead to
If successful, this could help doctors understand why some patients still have asthma attacks on tezepelumab and potentially improve treatment strategies.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly test a new therapy. Results may not lead to immediate changes in care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Guys & St Thomas NHS Foundation Trust
London, London, SE1 7EH, United Kingdom